248 related articles for article (PubMed ID: 7931486)
21. Decision-tree approach to the immunophenotype-based prognosis of the B-cell chronic lymphocytic leukemia.
Masić N; Gagro A; Rabatić S; Sabioncello A; Dasić G; Jaksić B; Vitale B
Am J Hematol; 1998 Oct; 59(2):143-8. PubMed ID: 9766799
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL).
Ling NR; Stevenson FK; Brown B
Clin Exp Immunol; 1991 Dec; 86(3):360-6. PubMed ID: 1721010
[TBL] [Abstract][Full Text] [Related]
23. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble CD23 in patients with hypogammaglobulinaemia.
Bansal AS; Haeney MR; Cochrane S; Pumphrey RS; Green LM; Bhavnani M; Wilson PB
Clin Exp Immunol; 1994 Aug; 97(2):239-41. PubMed ID: 8050171
[TBL] [Abstract][Full Text] [Related]
25. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Meuleman N; Stamatopoulos B; Dejeneffe M; El Housni H; Lagneaux L; Bron D
Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma.
Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O
Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491
[TBL] [Abstract][Full Text] [Related]
27. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
[TBL] [Abstract][Full Text] [Related]
28. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
29. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
[TBL] [Abstract][Full Text] [Related]
31. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
[TBL] [Abstract][Full Text] [Related]
32. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
33. CD23 and chronic lymphocytic leukemia.
Sarfati M
Blood Cells; 1993; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
[TBL] [Abstract][Full Text] [Related]
34. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis.
Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A
Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
36. [Correlational study between lymphocyte IgE markers: membrane CD23 (mCD23) and soluble CD23 (sCD23) in an atopic population].
Sabbah A; Buchmann C; Lauret MG; Drouet M
Allerg Immunol (Paris); 1993 Feb; 25(2):48-54. PubMed ID: 8466634
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia.
Christiansen I; Sundström C; Tötterman TH
Br J Haematol; 1998 Dec; 103(4):1129-37. PubMed ID: 9886331
[TBL] [Abstract][Full Text] [Related]
38. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
Chomarat P; Briolay J; Banchereau J; Miossec P
Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
[TBL] [Abstract][Full Text] [Related]
39. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
40. CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia.
Lavabre-Bertrand T; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Fégueux N; Poncelet P; Rousset T; Taïb J; Emberger JM; Navarro M
Leuk Lymphoma; 1994 Mar; 13(1-2):89-94. PubMed ID: 7517747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
